Skip to main content
Recall Canary
Minocycline Hydrochloride 115 mg Tablets
← Back to all recallsDRUG RECALL

Minocycline Hydrochloride 115 mg Tablets

Ascend Laboratories is recalling Minocycline Hydrochloride 115 mg tablets due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking your medication without consulting a medical professional.

Posted
Updated
Agency
FDA
Firm
Ascend Laboratories, LLC
Recall ID
99129
Status
ONGOING

Why it was recalled

Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, due to failed dissolution specifications. An out-of-specification result was observed during the 9th month of dissolution test analysis.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Minocycline Hydrochloride Extended-Release Tablets, USP

Strength
115 mg
NDC / UPC
NDC 67877-644-30

Official source

View on U.S. Food and Drug Administration →

Other recent recalls from Ascend Laboratories, LLC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-11 · primary source: U.S. Food and Drug Administration